Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA

Transfusion

Volumn 47, Issue 10, 2007, Pages 1783-1793

  Margaritis, Angelo R ^a   Brown, Stewart M ^a   Seed, Clive R ^a   Kiely, Philip ^a   D'Agostino, Bruno ^a   Keller, Anthony J ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; NUCLEIC ACID ANALYSIS; SENSITIVITY ANALYSIS; VIRUS DETECTION;

AUSTRALIA; AUTOMATION; BLOOD TRANSFUSION; DNA, VIRAL; HEPACIVIRUS; HEPATITIS B VIRUS; HIV; HONG KONG; HUMANS; RNA, VIRAL;

EID: 34548722779     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01343.x     Document Type: Article

References (30)

1. Mison L, Seed CR, Margaritis AR, Hyland C. Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies. Vox Sang 2003 84 : 11 9.
2. Busch MP, Glynn SA, Stramer SL, et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005 45 : 254 64.
3. Seed CR, Kiely P, Keller AJ. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Intern Med J 2005 35 : 592 8.
4. Kleinman S, Busch MP. Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol 2006 35 (Suppl S34 40.
5. Coste J, Reesink HW, Engelfriet CP, et al. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang 2005 88 : 289 303.
6. Biswas R, Tabor E, Hsia CC, et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003 43 : 788 98.
7. Comanor L, Holland P. Hepatitis B virus blood screening: unfinished agendas. Vox Sang 2006 91 : 1 12.
8. Koppelman MH, Assal A, Chudy M, et al. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations. Transfusion 2005 45 : 1258 66.
9. Kleinman SH, Strong DM, Tegtmeier GG, et al. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion 2005 45 : 1247 57.
10. Stramer SL, Brodsky JP, Preston S, et al. Comparative sensitivity of HBsAg and HBV NAT. Transfusion 2001 41 (Suppl 8S.
11. Sato S, Ohhashi W, Ihara H, Sakaya S, Kato T, Ikeda H. Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transfusion 2001 41 : 1107 13.
12. Ling AE, Robbins KE, Brown TM, et al. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period. Jama 2000 284 : 210 4.
13. Schuttler CG, Caspari G, Jursch CA, et al. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet 2000 355 : 41 2.
14. Giachetti C, Linnen JM, Kolk DP, et al. Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 2002 40 : 2408 19.
15. Saldanha J, Lelie N, Heath A. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. WHO Collaborative Study Group. Vox Sang 1999 76 : 149 58.
16. Saldanha J, Gerlich W, Lelie N, et al. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001 80 : 63 71.
17. McAuley J, Caglioti S, Robertson G, et al. Multi-site study of the Procleix Ultrio assay using the enhanced semi-automated system compared with the TIGRIS automated system [abstract]. Transfusion 2005 45 (Suppl 97A.
18. McCormick MK, Dockter J, Linnen JM, Kolk D, Wu Y, Giachetti C. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA. J Clin Virol 2006 36 : 166 76.
19. Guide to the preparation, use and quality assurance of blood components. 12th ed. Strasbourg : Council of Europe Publishing 2006.
20. Procleix Ultrio assay package insert. IN0167EN rev. 2. San Diego : Gen-Probe Inc. 2004.
21. cobas TaqScreen MPX Test v1.0 package insert. Pleasanton (CA) : Roche Molecular Systems 2006.
22. Assal A, Barlet V, Cornillot C, et al. Head to head comparison of two new automated NAT systems Chiron Procleic TIGRIS system vs Roche COBAS S201 [abstract]. Vox Sang 2006 91 (Suppl 3 75.
23. Herman S, Ohhashi Y, Kyger E, et al. Performance characteristics of a new multiplex NAT screening test for HBV, HCV and HIV. The COBAS TAQSCREEN MPX test on the COBAS S201 system [abstract]. Vox Sang 2006 91 (Suppl 3 81.
24. Jarvis L, Cleland A, Dunsford T, et al. Evaluation of the COBAS TAQSCREEN multiplex test and the S201 automated NAT platform in the Scottish National Blood Transfusion Service [abstract]. Vox Sang 2006 91 (Suppl 3 82 3.
25. Busch MP, Glynn SA, Wright DJ, et al. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection. Transfusion 2005 45 : 1853 63.
26. Kleinman SH, Kuhns MC, Todd DS, et al. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003 43 : 696 704.
27. Kuhns MC, Kleinman SH, McNamara AL, et al. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion 2004 44 : 1332 9.
28. Roth WK, Weber M, Petersen D, et al. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002 42 : 869 75.
29. Busch MP. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Transfus Clin Biol 2004 11 : 26 32.
30. Stramer SL. Pooled hepatitis B virus DNA testing by nucleic acid amplification: implementation or not. Transfusion 2005 45 : 1242 6.